AML1-ETO is determined by t (8; 21) (q22; Q22) chromosomal translocation of tumor proteins, which are seen in 1%–5% of patients with acute myeloid leukemia, most often in younger patients. The gene discussed is RUNX1; the disease is acute myeloid leukemia.